Building the regulator: OCM & the CCB

Legalizing cannabis is the easy part. Building a regulated cannabis market—licensing cultivators, processors, distributors, labs, and retailers; writing thousands of pages of rules; standing up a seed-to-sale tracking system—takes years. The OCM and the CCB spent most of 2021 and 2022 doing exactly that.

During that window, New York deliberately held the retail door shut. Conditional cultivation and processing licenses went out first, so that when dispensaries finally opened, there would actually be New York-grown, New York-tested product waiting on the shelves.

CAURD — a first-in-the-nation experiment

In 2022, the state launched the Conditional Adult-Use Retail Dispensary (CAURD) program. Rather than open licensing to the highest corporate bidders, CAURD reserved the first wave of adult-use retail licenses for two groups:

• Justice-involved individuals — people with a prior cannabis-related conviction, or a family member with one, who also had experience running a business.
• Qualifying nonprofits — organizations with a demonstrated history of service to justice-impacted communities.

The idea: before corporate chains could get a foothold, the communities most harmed by the war on drugs should get a running start. It remains one of the most ambitious social-equity frameworks any U.S. cannabis state has attempted.

December 29, 2022 — The first legal sale

On December 29, 2022, Housing Works Cannabis Co, a nonprofit on Broadway in Greenwich Village, made New York's first legal adult-use cannabis sale. Housing Works had spent decades fighting HIV/AIDS and homelessness in the city; operating the state's first dispensary was both a symbolic and practical expression of what MRTA was built to do.

Over the following months, a wave of CAURD storefronts opened across Manhattan, Brooklyn, the Hudson Valley, Buffalo, Binghamton, and beyond. Each one told a version of the same story: small operators, cultivators they actually knew, product they could trace.

Growing pains: lawsuits & the illicit market

The rollout wasn't clean. A series of federal lawsuits challenged residency and priority-licensing provisions, delaying openings in several regions for much of 2023. At the same time, thousands of unlicensed storefronts flooded New York City, offering untested product with no COA, no ID check, and no tax collection.

Through 2024 and 2025, the state pushed back on both fronts—expanding licensing classes beyond CAURD, funding local enforcement against unlicensed shops, and streamlining the path from cultivator to dispensary shelf. The regulated market steadily caught up. Hundreds of licensed dispensaries now operate statewide, and New York-licensed cultivators, processors, and labs have become a genuine industry.

Where we are in 2026

• The regulated market has overtaken the illicit market in several regions for the first time.
• New York cultivators are producing a maturing range of indoor, mixed-light, and outdoor flower with genuine terroir.
• Licensed on-site consumption lounges are beginning to roll out under separate OCM rules.
• Automatic conviction relief under the MRTA continues—tens of thousands of records sealed or expunged.
• Tax revenue from adult-use sales is directed to the state's Community Reinvestment Fund, drug-treatment programs, and public-education initiatives.

A brief timeline

• 1977 — New York decriminalizes small-quantity possession (but enforcement remained uneven for decades).
• 2014 — Compassionate Care Act launches New York's limited medical cannabis program.
• March 31, 2021 — MRTA signed into law.
• 2021–2022 — OCM & CCB stand up; conditional cultivation and processing licenses issued.
• Dec 29, 2022 — First legal adult-use sale at Housing Works Cannabis Co.
• 2023–2025 — CAURD expansion, litigation, enforcement, and licensing reform.
• 2026 — Licensed retail, lounges, and local cultivation anchor a growing, New York-centered market.